Comparison of Neutrophil-to-Albumin Ratio and Neutrophil-to-Lymphocyte Ratio in Acute Phase Positive and Negative Ankylosing Spondylitis Patients
Özet
Aim: Acute phase reactants may not always be positive in ankylosing spondylitis (AS). We herein aimed to investigate whether the neutrophil-to-albumin ratio (NAR) is useful in monitoring AS activity. Methods: One hundred nineteen patients who were followed up in the internal medicine rheumatology clinic between August 2024 and September 2024 and diagnosed with AS according to the axial spondyloarthropathy classification criteria of the Association for the Assessment of SpondyloArthritis international Society and the 1984 modified New York criteria were included in our study. The C-reactive protein (CRP), neutrophil-to-lymphocyte ratio (NLR), NAR and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) status of the patients were recorded at two visits, before and 6 months following treatment. Results: A significant correlation was found between the initial NLR and the NLR values after 6 months, and between the initial and 6-month BASDAI values in both the CRP positive and CRP negative groups (p=0.000 and p=0.017). It was observed that the changes in individual NAR and NLR values and BASDAI values for each case were parallel (p=0.012). Conclusion: C-reactive protein values in AS are not always consistent with disease activity, but the NLR may be helpful in such cases. As for the NA ratio, we found that each patient should be evaluated individually. © 2025 Galenos Publishing House. All rights reserved.
Anahtar Kelimeler
Tam Kayıt
| Alan | Değer | Dil |
|---|---|---|
| dc.contributor.author | Karatas, Beliz | |
| dc.date.accessioned | 2026-10-18T20:26:13.843220476Z | |
| dc.date.available | 2026-10-18T20:26:13.843220476Z | |
| dc.date.issued | 2025 | |
| dc.description.abstract | Aim: Acute phase reactants may not always be positive in ankylosing spondylitis (AS). We herein aimed to investigate whether the neutrophil-to-albumin ratio (NAR) is useful in monitoring AS activity. Methods: One hundred nineteen patients who were followed up in the internal medicine rheumatology clinic between August 2024 and September 2024 and diagnosed with AS according to the axial spondyloarthropathy classification criteria of the Association for the Assessment of SpondyloArthritis international Society and the 1984 modified New York criteria were included in our study. The C-reactive protein (CRP), neutrophil-to-lymphocyte ratio (NLR), NAR and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) status of the patients were recorded at two visits, before and 6 months following treatment. Results: A significant correlation was found between the initial NLR and the NLR values after 6 months, and between the initial and 6-month BASDAI values in both the CRP positive and CRP negative groups (p=0.000 and p=0.017). It was observed that the changes in individual NAR and NLR values and BASDAI values for each case were parallel (p=0.012). Conclusion: C-reactive protein values in AS are not always consistent with disease activity, but the NLR may be helpful in such cases. As for the NA ratio, we found that each patient should be evaluated individually. © 2025 Galenos Publishing House. All rights reserved. | |
| dc.identifier.doi | 10.4274/haseki.galenos.2025.09797 | |
| dc.identifier.eissn | 2147-2688 | |
| dc.identifier.endpage | 251 | |
| dc.identifier.issn | 1302-0072 | |
| dc.identifier.issue | 5 | |
| dc.identifier.scopus | 2-s2.0-105023644783 | |
| dc.identifier.startpage | 245 | |
| dc.identifier.uri | https://rdlopen.rawdatalibrary.net/r/ebyu/11133 | |
| dc.identifier.volume | 63 | |
| dc.language.iso | en | |
| dc.publisher | Galenos Publishing House | |
| dc.relation.ispartof | Haseki Tip Bulteni | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.subject | Ankylosing spondylitis | |
| dc.subject | neutrophil-to-albumin ratio | |
| dc.subject | neutrophil-to-lymphocyte ratio | |
| dc.subject | adalimumab | |
| dc.subject | C reactive protein | |
| dc.subject | colchicine | |
| dc.subject | duloxetine | |
| dc.subject | etanercept | |
| dc.subject | hydroxychloroquine | |
| dc.subject | infliximab | |
| dc.subject | methotrexate | |
| dc.subject | salazosulfapyridine | |
| dc.subject | adult | |
| dc.subject | Article | |
| dc.subject | Assessment of SpondyloArthritis international Society Health Index | |
| dc.subject | axial spondyloarthropathy | |
| dc.subject | Bath ankylosing spondylitis disease activity index | |
| dc.subject | Behcet disease | |
| dc.subject | controlled study | |
| dc.subject | Crohn disease | |
| dc.subject | diagnostic test accuracy study | |
| dc.subject | disease activity | |
| dc.subject | disease duration | |
| dc.subject | fatigue | |
| dc.subject | female | |
| dc.subject | fever | |
| dc.subject | fibromyalgia | |
| dc.subject | flow cytometry | |
| dc.subject | hip pain | |
| dc.subject | human | |
| dc.title | Comparison of Neutrophil-to-Albumin Ratio and Neutrophil-to-Lymphocyte Ratio in Acute Phase Positive and Negative Ankylosing Spondylitis Patients | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| rdl.citation.scopus | 0 | |
| rdl.citation.trdizin | 0 | |
| rdl.department | ERZİNCAN BİNALİ YILDIRIM ÜNİVERSİTESİ | |
| rdl.oa.status | gold | |
| rdl.source.index | SCOPUS | |
| rdl.source.index | TRDIZIN |
